The role of U.S. pharmacists in deprescribing: Recommendations based on a systematic literature review of qualitative studies

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Alina Cernasev , Devin Scott , Becka Eckert , Hilary Jasmin , David R. Axon
{"title":"The role of U.S. pharmacists in deprescribing: Recommendations based on a systematic literature review of qualitative studies","authors":"Alina Cernasev ,&nbsp;Devin Scott ,&nbsp;Becka Eckert ,&nbsp;Hilary Jasmin ,&nbsp;David R. Axon","doi":"10.1016/j.rcsop.2025.100625","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Deprescribing is increasingly investigated through a qualitative lens, yet no evidence synthesis of the extant qualitative deprescribing literature exists. This study aimed to identify and synthesize relevant qualitative data about the role of the pharmacist or pharmacy profession in deprescribing in the United States.</div></div><div><h3>Methods</h3><div>A systematic literature review was conducted in July 2024 in MEDLINE (PubMed), Scopus (Elsevier), and Embase (Elsevier). The primary search concepts included terms around pill burden, cessation and de-prescription, as well as a search string to narrow results to qualitative reports. From 4410 unique records after deduplication, 46 abstracts were included for full text review.</div></div><div><h3>Results</h3><div>After full text review, 11 records were deemed suitable for inclusion in this review. Three used interviews, five used focus groups, and three used both. Three studies used the theory of planned behavior, two studies used the capability, opportunity, and motivation behavior model, one used the chronic care model, one used the interprofessional shared decision-making model, one used grounded theory, and three did not use a framework. Studies were conducted in New York (<em>n</em> = 3), Arizona, Maine, and Tennessee (<em>n</em> = 3), California (<em>n</em> = 1), Iowa (<em>n</em> = 1), Massachusetts (<em>n</em> = 1), North Carolina (<em>n</em> = 1), and Rhode Island (<em>n</em> = 1). Key themes identified across the studies included enablers, obstacles, process of deprescribing, and deprescribing in pharmacy education.</div></div><div><h3>Conclusions</h3><div>Deprescribing is a complex process that involves the entire healthcare team, including pharmacists who have unique expertise to support the team through education and information about medication and disease states.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"19 ","pages":"Article 100625"},"PeriodicalIF":1.8000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667276625000666","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Deprescribing is increasingly investigated through a qualitative lens, yet no evidence synthesis of the extant qualitative deprescribing literature exists. This study aimed to identify and synthesize relevant qualitative data about the role of the pharmacist or pharmacy profession in deprescribing in the United States.

Methods

A systematic literature review was conducted in July 2024 in MEDLINE (PubMed), Scopus (Elsevier), and Embase (Elsevier). The primary search concepts included terms around pill burden, cessation and de-prescription, as well as a search string to narrow results to qualitative reports. From 4410 unique records after deduplication, 46 abstracts were included for full text review.

Results

After full text review, 11 records were deemed suitable for inclusion in this review. Three used interviews, five used focus groups, and three used both. Three studies used the theory of planned behavior, two studies used the capability, opportunity, and motivation behavior model, one used the chronic care model, one used the interprofessional shared decision-making model, one used grounded theory, and three did not use a framework. Studies were conducted in New York (n = 3), Arizona, Maine, and Tennessee (n = 3), California (n = 1), Iowa (n = 1), Massachusetts (n = 1), North Carolina (n = 1), and Rhode Island (n = 1). Key themes identified across the studies included enablers, obstacles, process of deprescribing, and deprescribing in pharmacy education.

Conclusions

Deprescribing is a complex process that involves the entire healthcare team, including pharmacists who have unique expertise to support the team through education and information about medication and disease states.
美国药剂师在处方中的作用:基于定性研究的系统文献综述的建议
目的越来越多地通过定性视角来研究处方,但没有证据综合现有的定性处方文献。本研究旨在识别和综合美国药剂师或药学专业在处方中的作用的相关定性数据。方法于2024年7月在MEDLINE (PubMed)、Scopus (Elsevier)和Embase (Elsevier)进行系统文献综述。主要的搜索概念包括围绕药片负担、戒烟和去处方的术语,以及将搜索结果缩小到定性报告的搜索字符串。从4410条重复数据删除后的唯一记录中,选取46篇摘要进行全文审查。结果经全文审阅后,11条记录被认为适合纳入本综述。三个使用访谈,五个使用焦点小组,三个两者都使用。3项研究使用计划行为理论,2项研究使用能力、机会和动机行为模型,1项研究使用慢性护理模型,1项研究使用跨专业共同决策模型,1项研究使用扎根理论,3项研究未使用框架。研究在纽约州(n = 3)、亚利桑那州、缅因州和田纳西州(n = 3)、加利福尼亚州(n = 1)、爱荷华州(n = 1)、马萨诸塞州(n = 1)、北卡罗来纳州(n = 1)和罗德岛州(n = 1)进行。研究中确定的关键主题包括促进因素、障碍、处方解除过程和药学教育中的处方解除。结论开处方是一个复杂的过程,涉及整个医疗团队,包括药剂师,他们有独特的专业知识,通过教育和药物和疾病状态的信息来支持团队。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信